Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Run-Jing Li"'
Autor:
Run-Jing Li, Jia-Jia Xu, Zheng-Hao Zhang, Min-Wei Chen, Shi-Xiao Liu, Cui Yang, Yan-Ling Li, Ping Luo, Yi-Jiang Liu, Rong Tang, Zhong-Gui Shan
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The progression from compensatory hypertrophy to heart failure is difficult to reverse, in part due to extracellular matrix fibrosis and continuous activation of abnormal signaling pathways. Although the anthraquinone rhein has been examined for its
Externí odkaz:
https://doaj.org/article/70a32215611e42deb7d416208073c24f
Autor:
Jia-jia Xu, Run-jing Li, Zheng-hao Zhang, Cui Yang, Shi-xiao Liu, Yan-ling Li, Min-wei Chen, Wei-wei Wang, Gong-ye Zhang, Gang Song, Zheng-rong Huang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Loganin is an iridoid glycoside extracted from Cornus officinalis, which is a traditional oriental medicine, and many biological properties of loganin have been reported. Nevertheless, it is not clear whether loganin has therapeutic effect on cardiov
Externí odkaz:
https://doaj.org/article/e8231d4df2f14495afc6e83324271a35
Autor:
Yi-jiang Liu, Cui Yang, Yan-ling Li, Jia-jia Xu, Min-wei Chen, Shi-xiao Liu, Xue-qi Wang, Xiang-hui Zheng, Ping Luo, Zheng-hao Zhang, Run-jing Li, Rui Li, Zhong-gui Shan
PURPOSE Bladder urothelial carcinoma (BLCA), the most common urinary tract malignancy, has a high recurrence rate and poor survival at late stages. Necroptosis, a form of programmed cell death, is involved in cancer development and progression, but i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c4dcbc0492c59a326514fd29ccfb4f4
https://doi.org/10.21203/rs.3.rs-2073511/v1
https://doi.org/10.21203/rs.3.rs-2073511/v1
Autor:
Zheng-hao Zhang, Zi-guan Zhang, Min-wei Chen, Ying Yang, Run-jing Li, Jia-jia Xu, Cui Yang, Yu-ying Li, Hong-wei Chen, Shi-xiao Liu, Yan-ling Li, Ping Luo, Yi-jiang Liu, Wen-bo Chen, Zhong-gui Shan, Zheng-rong Huang
Publikováno v:
Oxidative Medicine and Cellular Longevity.
The precise control of cardiomyocyte viability is imperative to combat myocardial ischemia-reperfusion injury (I/R), in which apoptosis and pyroptosis putatively contribute to the process. Recent researches indicated that GSDMD is involved in I/R as
Autor:
Zhengrong Huang, Jiajia Xu, Run-jing Li, Yan-ling Li, TzungDau Wang, Hongwei Chen, Xin Tu, Ziguan Zhang, Min-wei Chen, Shi-xiao Liu, Cui Yang, Wenbo Chen, Zheng-hao Zhang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
Objective: To investigate the genetic characteristics and transcriptional regulation of the SCN5A gene of Brugada syndrome (BrS) patients in China.Methods: Using PubMed, Medline, China National Knowledge Internet (CNKI), and Wanfang Database, Chinese
Autor:
Jiajia Xu, Yan-ling Li, Run-jing Li, Weiwei Wang, Gang Song, Gongye Zhang, Cui Yang, Zhengrong Huang, Zheng-hao Zhang, Min-wei Chen, Shi-xiao Liu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Loganin is an iridoid glycoside extracted from Cornus officinalis, which is a traditional oriental medicine, and many biological properties of loganin have been reported. Nevertheless, it is not clear whether loganin has therapeutic effect on cardiov